180 related articles for article (PubMed ID: 16189145)
21. Urine chemokines: biomarkers of human lupus nephritis?
Ferri GM; Gigante A; Ferri F; Amoroso D; Zardi E; Papa A; De Galasso L; Amoroso A
Eur Rev Med Pharmacol Sci; 2007; 11(3):171-8. PubMed ID: 17970233
[TBL] [Abstract][Full Text] [Related]
22. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
[TBL] [Abstract][Full Text] [Related]
23. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
[TBL] [Abstract][Full Text] [Related]
24. Regulation of Th1 and Th2 immune responses by chemokines.
Yoneyama H; Kawasaki S; Matsushima K
Springer Semin Immunopathol; 2000; 22(4):329-44. PubMed ID: 11155440
[No Abstract] [Full Text] [Related]
25. Switch from a dominant Th1-associated immune profile during the pre-diabetic phase in favour of a temporary increase of a Th3-associated and inflammatory immune profile at the onset of type 1 diabetes.
Ryden A; Stechova K; Durilova M; Faresjö M
Diabetes Metab Res Rev; 2009 May; 25(4):335-43. PubMed ID: 19382103
[TBL] [Abstract][Full Text] [Related]
26. Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases.
Echigo T; Hasegawa M; Shimada Y; Inaoki M; Takehara K; Sato S
Arch Dermatol Res; 2006 Jun; 298(1):38-45. PubMed ID: 16583210
[TBL] [Abstract][Full Text] [Related]
27. Chemoattractant mechanism of Th1 cells in class III and IV lupus nephritis.
Morimoto S; Tokano Y; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Suzuki J; Kaneko H; Sekigawa I; Takasaki Y
Autoimmunity; 2009 Feb; 42(2):143-9. PubMed ID: 19021013
[TBL] [Abstract][Full Text] [Related]
28. [Cytokines and chemokines in child physiopathology].
Nigro N
Minerva Pediatr; 1997 Sep; 49(9):415-7. PubMed ID: 9471545
[TBL] [Abstract][Full Text] [Related]
29. Chemokines as novel therapeutic targets for inflammatory bowel disease.
Nishimura M; Kuboi Y; Muramoto K; Kawano T; Imai T
Ann N Y Acad Sci; 2009 Sep; 1173():350-6. PubMed ID: 19758172
[TBL] [Abstract][Full Text] [Related]
30. CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production.
Romagnani P; Maggi L; Mazzinghi B; Cosmi L; Lasagni L; Liotta F; Lazzeri E; Angeli R; Rotondi M; Filì L; Parronchi P; Serio M; Maggi E; Romagnani S; Annunziato F
J Allergy Clin Immunol; 2005 Dec; 116(6):1372-9. PubMed ID: 16337473
[TBL] [Abstract][Full Text] [Related]
31. The pathophysiology of atopic eczema.
Allam JP; Novak N
Clin Exp Dermatol; 2006 Jan; 31(1):89-93. PubMed ID: 16309494
[TBL] [Abstract][Full Text] [Related]
32. Factors involved in the T helper type 1 and type 2 cell commitment and osteoclast regulation in inflammatory apical diseases.
Fukada SY; Silva TA; Garlet GP; Rosa AL; da Silva JS; Cunha FQ
Oral Microbiol Immunol; 2009 Feb; 24(1):25-31. PubMed ID: 19121066
[TBL] [Abstract][Full Text] [Related]
33. Histamine in idiopathic inflammatory bowel diseases--not a standby player.
Fogel W; Lewiński A; Jochem J
Folia Med Cracov; 2005; 46(3-4):107-18. PubMed ID: 17252993
[TBL] [Abstract][Full Text] [Related]
34. Expression of Th-1 chemokines and chemokine receptors on the ocular surface of C57BL/6 mice: effects of desiccating stress.
Yoon KC; De Paiva CS; Qi H; Chen Z; Farley WJ; Li DQ; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2561-9. PubMed ID: 17525185
[TBL] [Abstract][Full Text] [Related]
35. Chemokines and leukocyte traffic.
Sallusto F; Baggiolini M
Nat Immunol; 2008 Sep; 9(9):949-52. PubMed ID: 18711431
[TBL] [Abstract][Full Text] [Related]
36. Chemokines: inflammatory mediators of atherosclerosis.
Liehn EA; Zernecke A; Postea O; Weber C
Arch Physiol Biochem; 2006; 112(4-5):229-38. PubMed ID: 17178596
[TBL] [Abstract][Full Text] [Related]
37. The role of chemokines in inflammatory skin diseases.
Girolomoni G; Pastore S; Cavani A; Albanesi C
Ernst Schering Res Found Workshop; 2004; (44):191-225. PubMed ID: 14579781
[No Abstract] [Full Text] [Related]
38. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses.
Sallusto F; Lanzavecchia A; Mackay CR
Immunol Today; 1998 Dec; 19(12):568-74. PubMed ID: 9864948
[No Abstract] [Full Text] [Related]
39. Suppressive effects of ketotifen on Th1- and Th2-related chemokines of monocytes.
Hung CH; Suen JL; Hua YM; Chiang W; Chang HC; Chen CN; Jong YJ
Pediatr Allergy Immunol; 2007 Aug; 18(5):378-84. PubMed ID: 17617806
[TBL] [Abstract][Full Text] [Related]
40. Th1 and Th2 responses on the ocular surface in uveitis identified by CCR4 and CCR5 conjunctival expression.
Trinh L; Brignole-Baudouin F; Raphaël M; Dupont-Monod S; Cassoux N; Lehoang P; Baudouin C
Am J Ophthalmol; 2007 Oct; 144(4):580-5. PubMed ID: 17686449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
